Related Experiment Video
Updated: Mar 24, 2026

10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
19.4K
Using Intermediate Cognitive Endpoints to Facilitate Translational Research in Psychosis
Gary Gilmour1, Francois Gastambide1, Hugh M Marston1
1In Vivo Pharmacology, Eli Lilly & Co. Ltd., Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK.
Current Opinion in Behavioral Sciences
|March 4, 2016
Summary
New research suggests aberrant salience and prediction error are key to understanding psychosis. This could revolutionize drug discovery by linking molecular mechanisms to patient symptoms.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- The study of psychosis is shifting from empirical observation to hypothesis-driven research.
- Recent evidence implicates misattribution of salience and abnormal prediction error in psychosis.
Purpose of the Study:
- To explore how aberrant salience and prediction error can advance psychosis drug discovery.
- To establish causal links between molecular mechanisms and psychosis symptoms.
Main Methods:
- Assessing aberrant salience and prediction error using associative learning tests in animal models.
- Measuring neurotransmitter release and brain activity.
- Back-translation of findings from rodents to human patients.
Main Results:
- Aberrant salience and prediction error provide testable intermediate constructs for psychosis.
- Simple associative learning tests can assay these cognitive substrates.
- Combined methods allow for robust causal connections between molecular and symptomatic levels.
Conclusions:
- Intermediate constructs like aberrant salience and prediction error can significantly advance translational research in psychosis.
- This approach enables the establishment of direct causal links between neurobiology and psychosis symptoms.
- The findings pave the way for more effective, targeted drug discovery for psychosis.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
660
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
660
Psychosis and Antipsychotic Drugs: Overview
1.1K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.1K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.4K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.4K

